Virologic characteristics of subclinical and symptomatic genital herpes infections
about
HSV-2: in pursuit of a vaccineRegional distribution of antibodies to herpes simplex virus type 1 (HSV-1) and HSV-2 in men and women in Ontario, CanadaSlipping and sliding: frameshift mutations in herpes simplex virus thymidine kinase and drug-resistanceBlocking antibody access to neutralizing domains on glycoproteins involved in entry as a novel mechanism of immune evasion by herpes simplex virus type 1 glycoproteins C and EPredominance of herpes simplex virus type 1 from patients with genital herpes in Nova ScotiaThe seroepidemiology of herpes simplex virus type 1 and 2 in EuropeSeroepidemiology of Herpes Simplex virus type 1 and 2 in Western and Southern Switzerland in adults aged 25-74 in 1992-93: a population-based studyPrevention of genital herpes in a guinea pig model using a glycoprotein D-specific single chain antibody as a microbicideHerpes simplex virus type 2 and HIV disease progression: a systematic review of observational studiesMathematical modeling of herpes simplex virus-2 suppression with pritelivir predicts trial outcomes.Mathematical Modeling Predicts that Increased HSV-2 Shedding in HIV-1 Infected Persons Is Due to Poor Immunologic Control in Ganglia and Genital MucosaLongitudinal study on oral shedding of herpes simplex virus 1 and varicella-zoster virus in individuals infected with HIVPsychological distress, emotional stability, and emotion regulation moderate dynamics of herpes simplex virus type 2 recurrence.Comparative clinical evaluation of the IsoAmp(®) HSV Assay with ELVIS(®) HSV culture/ID/typing test system for the detection of herpes simplex virus in genital and oral lesions.A rapid and simple isothermal nucleic acid amplification test for detection of herpes simplex virus types 1 and 2.Oral shedding of herpes simplex virus type 2.Virologic and immunologic evidence of multifocal genital herpes simplex virus 2 infection.HLA Class I and II alleles, heterozygosity and HLA-KIR interactions are associated with rates of genital HSV shedding and lesions.Impact of HIV infection and Kaposi sarcoma on human herpesvirus-8 mucosal replication and dissemination in Uganda.Seroprevalence and factors associated with herpes simplex virus type 2 among HIV-negative high-risk men who have sex with men from Rio de Janeiro, Brazil: a cross-sectional studyFrequent release of low amounts of herpes simplex virus from neurons: results of a mathematical model.Detection and direct typing of herpes simplex virus in perianal ulcers of patients with AIDS by PCR.Herpes simplex virus type 1 renders infected cells resistant to cytotoxic T-lymphocyte-induced apoptosis.The quantity of latent viral DNA correlates with the relative rates at which herpes simplex virus types 1 and 2 cause recurrent genital herpes outbreaks.Improving the care of patients with genital herpes.Neutralizing antibodies inhibit axonal spread of herpes simplex virus type 1 to epidermal cells in vitro.Localization of a passively transferred human recombinant monoclonal antibody to herpes simplex virus glycoprotein D to infected nerve fibers and sensory neurons in vivo.Prospects for control of herpes simplex virus disease through immunization.Herpes simplex virus infections. New treatment approaches make early diagnosis even more important.Prevalence and factors associated with herpes simplex virus type 2 infection in patients attending a Baltimore City emergency department.Evaluation of three glycoprotein G2-based enzyme immunoassays for detection of antibodies to herpes simplex virus type 2 in human sera.Development of a high-throughput quantitative assay for detecting herpes simplex virus DNA in clinical samples.Quantitative stability of DNA after extended storage of clinical specimens as determined by real-time PCR.Recent progress in herpes simplex virus immunobiology and vaccine researchGenital herpes: review of the epidemic and potential use of type-specific serologyCivamide (cis-capsaicin) for treatment of primary or recurrent experimental genital herpesComparison of a monoclonal antibody-blocking enzyme-linked immunoassay and a strip immunoblot assay for identifying type-specific herpes simplex virus type 2 serological responses.Novel approach for specific detection of herpes simplex virus type 1 and 2 antibodies and immunoglobulin G and M antibodies.Recent advances in management of genital herpes.Three phase III randomized controlled trials of topical resiquimod 0.01-percent gel to reduce anogenital herpes recurrences.
P2860
Q22306291-AB3087E6-DBE0-4AEA-876A-2D62A9FD559BQ24550624-204018FB-EA88-442C-9A16-45F239E1240BQ24634966-2DFDF2D1-B1E6-47C4-8213-F4D1E6AF2953Q24646778-87021090-B488-484E-9420-F7B42E39EB30Q24670332-13A9FFDF-9CD7-4E1B-88F3-0364836A0D61Q24679583-DD3CE245-8B7B-4456-99F7-AD59F0EC8B65Q24791873-D0A82E1B-414B-4B73-A721-4F9C97C8CAA8Q24803342-AC1327E4-EE49-42F0-842C-7FFB54CAC6FCQ26861777-7650A443-0732-4DAD-9779-5D3C91635BDBQ27324453-808F7120-7327-4C9E-BA1C-114938CBF01FQ27347896-7271257F-668A-48E9-BD45-EAFBFE386227Q28660303-9D04C732-13D2-4A2F-B8E3-224242B2D822Q30303142-3D41EBE1-CB22-408A-9B03-82FB9AC123B3Q30417946-54106F8C-4A66-43EE-AED5-4B1C0B7044D9Q30429126-C67E981D-0C3E-4381-9B61-6A22C4A58F9DQ30478605-544EB022-332E-4448-BD82-26EFA57F162CQ30576590-E31BCAE9-13FB-4116-B7EC-B309E7ECD14DQ30830481-A468C4E6-3E9A-4D21-9072-672F271B025DQ33401242-1D39A776-6AFC-4188-B085-0BC3DD10B33BQ33425027-8806D8B5-99B8-4119-BEE5-57E16C673BE2Q33638754-2890820D-37E5-4EDA-AB44-0EAF68248ACBQ33660740-A736E719-A57D-4AD0-AC9D-42A53F29318CQ33782022-1B23B873-6F7F-4A01-9C68-EE49B2C17182Q33783025-D7048F0D-DDCD-406B-ACD0-CCF0674134CCQ33801850-70A859D4-6769-491B-9F42-0E3CCFD95ABCQ33815811-C6516716-AB3A-4E7A-9187-85C0DE8A1607Q33821358-FDB9D172-AE0F-4C3D-8159-A86CD14E88AFQ33866424-9BA125A0-69A6-47E9-854E-A3DD60BEBBDCQ33869777-839C5BEE-5256-4D20-8A74-9F2330E5F86CQ33921519-3338C9AD-3360-4F6C-A7B1-16EC5D9EEF03Q33959969-CA8DAE7A-BD7F-491A-9682-DF967A6F4168Q33960980-D8DCD8C8-88DF-44AE-9DF2-821E46DF3564Q33963010-39E240B8-F635-4D0D-BCF0-BC6099C49ACCQ33963713-F550F1F1-54DA-4F70-A710-61F1FE560A1DQ33975387-C2FC29BB-608A-47E4-B7FC-2C93B8638B42Q33978036-80605727-1219-4596-91B2-CC702FB16C62Q33998516-AC7D43E1-F0C0-41D6-BF8E-D558AC97D784Q33998722-51352863-5BA3-45D1-8898-792F297B0FC6Q34012149-FA864158-B205-4F3E-95F0-244254A1BAE2Q34057360-9AB85493-F7F3-45F4-95B8-A2E85F858A7D
P2860
Virologic characteristics of subclinical and symptomatic genital herpes infections
description
1995 nî lūn-bûn
@nan
1995 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Virologic characteristics of subclinical and symptomatic genital herpes infections
@ast
Virologic characteristics of subclinical and symptomatic genital herpes infections
@en
Virologic characteristics of subclinical and symptomatic genital herpes infections
@nl
type
label
Virologic characteristics of subclinical and symptomatic genital herpes infections
@ast
Virologic characteristics of subclinical and symptomatic genital herpes infections
@en
Virologic characteristics of subclinical and symptomatic genital herpes infections
@nl
prefLabel
Virologic characteristics of subclinical and symptomatic genital herpes infections
@ast
Virologic characteristics of subclinical and symptomatic genital herpes infections
@en
Virologic characteristics of subclinical and symptomatic genital herpes infections
@nl
P2093
P3181
P1476
Virologic characteristics of subclinical and symptomatic genital herpes infections
@en
P2093
P3181
P356
10.1056/NEJM199509213331205
P407
P50
P577
1995-09-21T00:00:00Z